Alemtuzumab as consolidation after a response to fludarabine is effective in purging residual disease in patients with chronic lymphocytic leukemia

Marco Montillo, Alessandra Tedeschi, Sara Miqueleiz, Silvio Veronese, Roberto Cairoli, Liliana Intropido, Francesca Ricci, Anna Colosimo, Barbara Scarpati, Michela Montagna, Michele Nichelatti, Mario Regazzi, Enrica Morra

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Alemtuzumab as consolidation after a response to fludarabine is effective in purging residual disease in patients with chronic lymphocytic leukemia'. Together they form a unique fingerprint.

Medicine & Life Sciences